Protagonist Therapeutics, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ABOS
Acumen Pharmaceuticals, Inc. |
$1.85 | $157.41 M | -2.5 | 51 | $0 |
![]() AKRO
Akero Therapeutics, Inc. |
$27.64 | $1.59 B | -7.1 | 63 | $0 |
![]() ARVN
Arvinas, Inc. |
$19.91 | $1.83 B | -4.41 | 430 | $263.40 M |
![]() BDTX
Black Diamond Therapeutics, Inc. |
$2.13 | $291.95 M | -3.13 | 24 | $0 |
![]() CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $7.29 B | -14.66 | 355 | $0 |
![]() DAWN
Day One Biopharmaceuticals, Inc. |
$12.20 | $1.12 B | -5.11 | 181 | $131.16 M |
![]() HOOK
HOOKIPA Pharma Inc. |
$1.84 | $79.07 M | -1.71 | 82 | $0 |
![]() IDYA
IDEAYA Biosciences, Inc. |
$25.69 | $2.88 B | -19 | 131 | $7.00 M |
![]() KURA
Kura Oncology, Inc. |
$8.51 | $1.66 B | -10.03 | 192 | $53.88 M |
![]() MRUS
Merus N.V. |
$42.39 | $3.50 B | -19.38 | 260 | $36.13 M |
![]() PLRX
Pliant Therapeutics, Inc. |
$13.18 | $672.63 M | -3.9 | 171 | $0 |
![]() REPL
Replimune Group, Inc. |
$12.02 | $485.18 M | -2.44 | 331 | $0 |
![]() RLAY
Relay Therapeutics, Inc. |
$4.57 | $1.05 B | -3 | 261 | $10.01 M |
![]() RNA
Avidity Biosciences, Inc. |
$31.42 | $2.54 B | -8.99 | 391 | $10.90 M |
![]() RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
![]() SNDX
Syndax Pharmaceuticals, Inc. |
$13.69 | $1.66 B | -6.02 | 270 | $23.68 M |
![]() STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
![]() TERN
Terns Pharmaceuticals, Inc. |
$5.71 | $462.44 M | -5.67 | 66 | $0 |
![]() VRNA
Verona Pharma plc |
$44.81 | $983.52 M | -15.16 | 209 | $42.28 M |
![]() VTYX
Ventyx Biosciences, Inc. |
$2.42 | $229.83 M | -1.01 | 79 | $0 |
![]() XFOR
X4 Pharmaceuticals, Inc. |
$0.74 | $169.62 M | -1.51 | 143 | $0 |